Myriad Genetics (MYGN) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $5.92 -4.21%
Revenue Growth %: -3.3%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
PEBK, DIT, AMC, More
Revenue Growth %: -3.3%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $173.1 million versus the consensus estimate of $156.2 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- AGNC Investment Corp (AGNC) Tops Q2 EPS by 2c
- Crown Holdings (CCK) Tops Q2 EPS by 33c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
